© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
September 19, 2008
We conducted 2 feasibility studies to assess the performance and safety of the percutaneous left atrial appendage (LAA) transcatheter occlusion system for the prevention of stroke in high-risk patients with nonrheumatic atrial fibrillation. Results showed that percutaneous LAA occlusion can be performed using the device at acceptable risk. This procedure may be particularly useful for patients at increased risk of ischemic stroke with a contraindication to anticoagulation therapy.
Local Approach Needed to Increase Hepatitis B Vaccinations in Indonesia
Study Finds Increased Risk of Psoriasis for Patients with Herpes Zoster
Both Ustekinumab, Vedolizumab Safe and Efficacious Treating Elderly Patients With IBD